Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
LGC Group
LGC Group
Activities:
Manufacturing
Packaging
Regulatory
Analysis
Pharmaceutical
Active Nutrition
Food
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
N4 Pharma and SRI to target and treat previously unreachable human cells
The companies will collaborate to perform research to conjugate SRI’s MGS system to Nuvec to increase intracellular delivery to specific target cells.
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Finance
LGC acquires NGS kit supplier
Rapid Genomics provides kits to help enable the development of more productive and resilient plants and animals
Research & Development
LGC announces Validate ISx for Abbott and Siemens platforms
Use of this product, the company says, assists with fulfilling various quality control requirements – such as analytical measurement range (AMR) and reportable range
Ingredients
LGC releases clinical diagnostic kit for COVID-19 variant analysis
This solution is compatible with multiple applications, including performance confirmation for existing SARS-CoV-2 molecular assays as well as SARS-CoV-2 variant genotyping or NGS assays
Regulatory
LGC SARS-CoV-2 testing system granted emergency use authorisation
The FDA’s authorisation enables qualified laboratories to address testing demands while providing significant economic advantage, LGC says
Finance
LGC acquires Paragon Scientific
Founded in 1994, Paragon employs 22 people in the North West of England with two facilities located in Birkenhead and is accredited to ISO 17025 and ISO 17034
Finance
LGC acquires Technopath Clinical Diagnostics
The move is aimed to strengthen LGC's clinical quality controls
Analysis
LGC offers regulated bioanalysis on mass spectrometry platform
The platform offers enhanced levels of selectivity and mass accuracy, LGC says
Subscribe now